Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster ...

During the first quarter of 2025, the Harbor Dividend Growth Leaders ETF returned –4.27%, underperforming the ETF’s style ...

Village Health Workers in Zimbabwe use digital medical equipment and smartphones to diagnose and treat childhood ...

Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and ...

ACS will honor researchers and companies as Heroes of Chemistry for creating and enhancing products that have led to ...

The market seems to share this optimistic view, since Eli Lilly and has a short interest of only 0.9% (this is the percentage ...

Indian-origin psychiatrist and former CEO of Sovereign Health Group, Dr. Tonmoy Sharma, was arrested by federal authorities ...

Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...